guardant health将参加即将举行的投资者会议。 Guardant Health, Inc.(纳斯达克:GH)是一家领先的精准肿瘤医疗公司,今日宣布公司将参加以下投资者会议。 ● 古根海姆首届医疗创新大会 Businesswire11/01 19:00 GH将于11月06日盘后发布财报,一图速览分析师最新预测 富途资讯11/01 09:00 摩根士丹利维持Guardant Health...
Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early Oct. 4, 2018 at 11:01 a.m. ETby Emma Court Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes Sep. 17, 2018 at 9:06 a.m. ETby Emma Court ...
Guardant Health, Inc. Common Stock (GH) After-Hours 最新更新数据 Oct 29, 2024 08:00 PM ET. 本页面恢复更新时间 Oct 30, 2024 04:00 PM ET. Latest After-Hours Trades -> View Latest After-Hours Trades -> 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4...
Technology These Stocks Moved the Most Today: Deckers Outdoor, Intuit, Workday, Ross Stores, Nvidia, Guardant Health, and More May. 24, 2024 at 4:16 p.m. ET by Barron's Other News Press Releases TMUS to Boost Fan Experience at Las Vegas Grand Prix: Stock to Gain? Nov. 19, ...
Guardant Health has granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts a...
Jim Cramer takes a look at Berkshire Hathaway, Seattle Genetics, Zynerba Pharmaceuticals, Range Resources, Guardant Health, Danaher and more. RRCGHDHR Stock Investing News, Analysis and Tips Feb 23, 2018 1:25 PM EST Oil Rally Seen as Temporary as Prices Set to Fluctuate This Year A stronger...
Liquidation Price Participation Conversion Price Anti Dilution General Voting $XXM Board Voting $XXM Par Value Learn more by requesting a demo ObvioHealth Investors 8 Investors ObvioHealth has 8 investors. Guardant Health invested in ObvioHealth's Series B - III funding round. First funding...
Price $51.48 Nov 8, 2024 Fair Value $68.00 Nov 6, 2024 Uncertainty Very High 1-Star Price $119.00 5-Star Price $34.00 Economic Moat None Capital Allocation Standard Bulls Say, Bears Say Bulls Cologuard’s staying power remains underappreciated, as its superior detection of precancerous lesions...
GUARDANT HEALTH, INC. -3.64%+1.75%+25.04%-72.36%3.6B ANDON HEALTH CO., LTD. -1.13%-4.57%+21.69%+391.60%2.85B VITROLIFE AB -2.56%-8.17%+27.47%-58.69%2.72B SANSURE BIOTECH INC. -1.96%-4.58%+25.89%-40.77%1.79B SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD. ...
Schrodinger Price To Book Ratio -19.40-19.417.624.412.974.684.92-20.00-20.00-15.00-10.00-5.000.005.00L2018201920202021202220232024Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the ...